The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
The global In-Vitro Toxicity Testing market was valued at US$ 9889.1 million in 2023 and is anticipated to reach US$ 17060 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
A significant driver in the In-Vitro Toxicity Testing market is the increasing focus on alternatives to traditional animal testing methods in pharmaceutical and chemical industries. In-Vitro toxicity testing offers a more ethical and cost-effective approach to assess the safety and toxicity of chemicals and drugs. However, a notable challenge in this market is the need for regulatory acceptance and standardization of in-vitro testing methods. Ensuring that in-vitro tests gain regulatory approval and are universally recognized as accurate predictors of toxicity poses a significant challenge. Manufacturers and regulatory bodies must collaborate to establish robust validation processes and harmonized guidelines to facilitate the wider adoption of in-vitro toxicity testing while ensuring the safety of products and environmental protection.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Toxicity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Toxicity Testing.
Report Scope
The In-Vitro Toxicity Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Toxicity Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Toxicity Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Thermo Fisher Scientific
- Covance
- Bio-Rad Laboratories
- GE Healthcare
- Eurofins Scientific
- Merck KGaA
- Charles River Laboratories
- Catalent
- Cyprotex
- QIAGEN
- Promega
- Gentronix
- BioIVT
- MB Research Laboratories
Segment by Type
- Cell Culture Technologies
- High-throughput Technologies
- Toxicogenomics
Segment by Application
- Pharmaceuticals & Biopharmaceuticals
- Cosmetic & Household Products
- Food
- Chemicals
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Toxicity Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicity Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Culture Technologies
1.2.3 High-throughput Technologies
1.2.4 Toxicogenomics
1.3 Market by Application
1.3.1 Global In-Vitro Toxicity Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals & Biopharmaceuticals
1.3.3 Cosmetic & Household Products
1.3.4 Food
1.3.5 Chemicals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Toxicity Testing Market Perspective (2019-2030)
2.2 In-Vitro Toxicity Testing Growth Trends by Region
2.2.1 Global In-Vitro Toxicity Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Vitro Toxicity Testing Historic Market Size by Region (2019-2024)
2.2.3 In-Vitro Toxicity Testing Forecasted Market Size by Region (2025-2030)
2.3 In-Vitro Toxicity Testing Market Dynamics
2.3.1 In-Vitro Toxicity Testing Industry Trends
2.3.2 In-Vitro Toxicity Testing Market Drivers
2.3.3 In-Vitro Toxicity Testing Market Challenges
2.3.4 In-Vitro Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Toxicity Testing Players by Revenue
3.1.1 Global Top In-Vitro Toxicity Testing Players by Revenue (2019-2024)
3.1.2 Global In-Vitro Toxicity Testing Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Toxicity Testing Revenue
3.4 Global In-Vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicity Testing Revenue in 2023
3.5 In-Vitro Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-Vitro Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-Vitro Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicity Testing Historic Market Size by Type (2019-2024)
4.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Type (2025-2030)
5 In-Vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicity Testing Historic Market Size by Application (2019-2024)
5.2 Global In-Vitro Toxicity Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Vitro Toxicity Testing Market Size (2019-2030)
6.2 North America In-Vitro Toxicity Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Vitro Toxicity Testing Market Size by Country (2019-2024)
6.4 North America In-Vitro Toxicity Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Toxicity Testing Market Size (2019-2030)
7.2 Europe In-Vitro Toxicity Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Vitro Toxicity Testing Market Size by Country (2019-2024)
7.4 Europe In-Vitro Toxicity Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicity Testing Market Size (2019-2030)
8.2 Asia-Pacific In-Vitro Toxicity Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Vitro Toxicity Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Toxicity Testing Market Size (2019-2030)
9.2 Latin America In-Vitro Toxicity Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Vitro Toxicity Testing Market Size by Country (2019-2024)
9.4 Latin America In-Vitro Toxicity Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicity Testing Market Size (2019-2030)
10.2 Middle East & Africa In-Vitro Toxicity Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Covance
11.2.1 Covance Company Detail
11.2.2 Covance Business Overview
11.2.3 Covance In-Vitro Toxicity Testing Introduction
11.2.4 Covance Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.2.5 Covance Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Detail
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare In-Vitro Toxicity Testing Introduction
11.4.4 GE Healthcare Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.4.5 GE Healthcare Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific In-Vitro Toxicity Testing Introduction
11.5.4 Eurofins Scientific Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.5.5 Eurofins Scientific Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA In-Vitro Toxicity Testing Introduction
11.6.4 Merck KGaA Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.6.5 Merck KGaA Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Detail
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories In-Vitro Toxicity Testing Introduction
11.7.4 Charles River Laboratories Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.7.5 Charles River Laboratories Recent Development
11.8 Catalent
11.8.1 Catalent Company Detail
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicity Testing Introduction
11.8.4 Catalent Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.8.5 Catalent Recent Development
11.9 Cyprotex
11.9.1 Cyprotex Company Detail
11.9.2 Cyprotex Business Overview
11.9.3 Cyprotex In-Vitro Toxicity Testing Introduction
11.9.4 Cyprotex Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.9.5 Cyprotex Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN In-Vitro Toxicity Testing Introduction
11.10.4 QIAGEN Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.10.5 QIAGEN Recent Development
11.11 Promega
11.11.1 Promega Company Detail
11.11.2 Promega Business Overview
11.11.3 Promega In-Vitro Toxicity Testing Introduction
11.11.4 Promega Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.11.5 Promega Recent Development
11.12 Gentronix
11.12.1 Gentronix Company Detail
11.12.2 Gentronix Business Overview
11.12.3 Gentronix In-Vitro Toxicity Testing Introduction
11.12.4 Gentronix Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.12.5 Gentronix Recent Development
11.13 BioIVT
11.13.1 BioIVT Company Detail
11.13.2 BioIVT Business Overview
11.13.3 BioIVT In-Vitro Toxicity Testing Introduction
11.13.4 BioIVT Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.13.5 BioIVT Recent Development
11.14 MB Research Laboratories
11.14.1 MB Research Laboratories Company Detail
11.14.2 MB Research Laboratories Business Overview
11.14.3 MB Research Laboratories In-Vitro Toxicity Testing Introduction
11.14.4 MB Research Laboratories Revenue in In-Vitro Toxicity Testing Business (2019-2024)
11.14.5 MB Research Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
